{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:10Z","timestamp":1786120390834,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/ppo.0b013e318243f785","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T22:55:52Z","timestamp":1327618552000},"page":"51-58","source":"Crossref","is-referenced-by-count":9,"title":["Outside the Box\u2014Novel Therapeutic Strategies for Glioblastoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Maciej M.","family":"Mrugala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Adair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":". Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1517\/13543784.17.8.1225","article-title":". Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.","volume":"17","author":"Reardon","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1200\/JCO.2008.21.6895","article-title":". Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.","volume":"27","author":"Grossman","year":"2009","journal-title":"J Clin Oncol"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/neuonc\/noq071","article-title":". A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.","volume":"12","author":"Rosenfeld","year":"2010","journal-title":"Neuro Oncol"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2008.5.17557","article-title":". Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.","volume":"110","author":"McGirt","year":"2009","journal-title":"J Neurosurg"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"10152","DOI":"10.1073\/pnas.0702916104","article-title":". Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.","volume":"104","author":"Kirson","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2006.08.1117","article-title":". Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.","volume":"25","author":"Kunwar","year":"2007","journal-title":"J Clin Oncol"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/nop054","article-title":". Phase III randomized trial of CED of IL13-PE38QQR vs gliadel wafers for recurrent glioblastoma.","volume":"12","author":"Kunwar","year":"2010","journal-title":"Neuro Oncol"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(78)90099-5","article-title":". One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell.","volume":"15","author":"Yamaizumi","year":"1978","journal-title":"Cell"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.36.5.539","article-title":". Transferrin receptors in human tissues: their distribution and possible clinical relevance.","volume":"36","author":"Gatter","year":"1983","journal-title":"J Clin Pathol"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jconrel.2006.12.001","article-title":". Inhibition of transferrin iron release increases in vitro drug carrier efficacy.","volume":"117","author":"Lao","year":"2007","journal-title":"J Control Release"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ddr.20272","article-title":"Molecular targeting with recombinant cytotoxins for the treatment of brain tumors.","volume":"69","author":"Debinski","year":"2008","journal-title":"Drug Dev Res"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-009-9932-2","article-title":". Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.","volume":"95","author":"Oh","year":"2009","journal-title":"J Neurooncol"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"12846","DOI":"10.1073\/pnas.97.23.12846","article-title":". Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.","volume":"97","author":"Aboody","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-10-20210203","first-page":"63","article-title":". Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.","volume":"25","author":"Lee","year":"2011","journal-title":"Oncol Rep"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001756-199512290-00082","article-title":"Human astrocytoma cells express a unique chloride current.","volume":"7","author":"Ullrich","year":"1995","journal-title":"Neuroreport"},{"key":"R21-10-20210203","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00001756-199604100-00013","article-title":"Human astrocytoma cells express a unique chloride current.","volume":"7","author":"Ullrich","year":"1996","journal-title":"Neuroreport"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00456-9","article-title":". Expression of voltage-activated chloride currents in acute slices of human gliomas.","volume":"83","author":"Ullrich","year":"1998","journal-title":"Neuroscience"},{"key":"R23-10-20210203","first-page":"4871","article-title":". Use of chlorotoxin for targeting of primary brain tumors.","volume":"58","author":"Soroceanu","year":"1998","journal-title":"Cancer Res"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"key":"R25-10-20210203","first-page":"39","article-title":". Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide.","volume":"30","author":"Jacoby","year":"2010","journal-title":"Anticancer Res"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":". Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.","volume":"24","author":"Mamelak","year":"2006","journal-title":"J Clin Oncol"},{"key":"R27-10-20210203","first-page":"580","article-title":". Imaging glioma extent with 131I-TM-601.","volume":"46","author":"Hockaday","year":"2005","journal-title":"J Nucl Med"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":". Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3171\/jns.2000.93.6.1003","article-title":". Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.","volume":"93","author":"Stummer","year":"2000","journal-title":"J Neurosurg"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1215\/15228517-2008-052","article-title":". Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients.","volume":"10","author":"Pichlmeier","year":"2008","journal-title":"Neuro Oncol"},{"key":"R33-10-20210203","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/smll.200700784","article-title":". In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.","volume":"4","author":"Sun","year":"2008","journal-title":"Small"},{"key":"R34-10-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/17435889.3.4.495","article-title":". Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.","volume":"3","author":"Sun","year":"2008","journal-title":"Nanomedicine (Lond)"},{"key":"R35-10-20210203","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/smll.200800646","article-title":". Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles.","volume":"5","author":"Veiseh","year":"2009","journal-title":"Small"},{"key":"R36-10-20210203","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2106\/00004623-198769070-00026","article-title":"Electrical stimulation of repair of bone.","volume":"69","author":"Bassett","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"R37-10-20210203","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/0008-5472.CAN-04-0083","article-title":". Disruption of cancer cell replication by alternating electric fields.","volume":"64","author":"Kirson","year":"2004","journal-title":"Cancer Res"},{"issue":"Pt 3","key":"R38-10-20210203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/jcs.102.3.401","article-title":"Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis.","volume":"102","author":"Jordan","year":"1992","journal-title":"J Cell Sci"},{"key":"R39-10-20210203","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol).","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"R40-10-20210203","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1667\/0033-7587(2000)153[0036:CVTLMS]2.0.CO;2","article-title":". Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells.","volume":"153","author":"Endlich","year":"2000","journal-title":"Radiat Res"},{"key":"R41-10-20210203","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1200\/JCO.1999.17.8.2572","article-title":". Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials.","volume":"17","author":"Wong","year":"1999","journal-title":"J Clin Oncol"},{"key":"R44-10-20210203","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0b013e3181bc0184","article-title":". Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.","volume":"73","author":"Iwamoto","year":"2009","journal-title":"Neurology"},{"key":"R45-10-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6649-9-1","article-title":". Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields).","volume":"9","author":"Kirson","year":"2009","journal-title":"BMC Med Phys"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00130404-201201000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:08Z","timestamp":1786048268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130404-201201000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e318243f785","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}